Work

Standard tyrosine kinase inhibitor dose versus dose de-escalation prior to treatment-free remission attempt in chronic myeloid leukemia: A single-center 25-year retrospective study

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-2011

Authors: Mark Pusung, Christopher Eide, Nicola Long, Cristina Tognon, Andy Kaempf, Diana Brewer, Theodore Braun, Michael Heinrich, Brian Druker

Institutions: Oregon Health & Science University, OHSU Knight Cancer Institute

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417013598

Cites:

Cited by:

Related to: